Neurowyzr, a Singapore-based healthtech company specializing in enhancing brain health and developing state-of-the-art technologies to mitigate early brain decline, has raised an additional $2.1 million in an oversubscribed seed round. The round, jointly led by Jungle Ventures and Peak XV’s Surge (formerly Sequoia India and Southeast Asia), with participation from various angel investors, brings the total amount raised by the company to $3.3 million.